Your browser doesn't support javascript.
loading
Evaluation of the Potential for QTc Prolongation With Repeated Oral Doses of Fedratinib in Patients With Advanced Solid Tumors.
Ogasawara, Ken; Xu, Christine; Yin, Jian; Darpo, Borje; Carayannopoulos, Leon; Xue, Hongqi; Palmisano, Maria; Krishna, Gopal.
  • Ogasawara K; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Xu C; Sanofi, Bridgewater, New Jersey, USA.
  • Yin J; Sanofi, Bridgewater, New Jersey, USA.
  • Darpo B; ERT, Philadelphia, Pennsylvania, USA.
  • Carayannopoulos L; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Xue H; ERT, Philadelphia, Pennsylvania, USA.
  • Palmisano M; Bristol Myers Squibb, Summit, New Jersey, USA.
  • Krishna G; Bristol Myers Squibb, Summit, New Jersey, USA.
Clin Pharmacol Drug Dev ; 10(4): 366-375, 2021 04.
Article en En | MEDLINE | ID: mdl-32673446
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinas / Sulfonamidas / Inhibidores de las Cinasas Janus / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirrolidinas / Sulfonamidas / Inhibidores de las Cinasas Janus / Neoplasias Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2021 Tipo del documento: Article